Copyright Reports & Markets. All rights reserved.

Global Hypertension Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Hypertension Drug Market Overview

      • 1.1 Product Overview and Scope of Hypertension Drug
      • 1.2 Hypertension Drug Segment by Type
        • 1.2.1 Global Hypertension Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Calcium Channel Blockers
        • 1.2.3 Diuretics
        • 1.2.4 Beta Blockers Vasodilators
        • 1.2.5 Angiotensin Converting Enzyme Inhibitors
        • 1.2.6 Alpha Blockers
        • 1.2.7 Angiotensin Receptor Blockers
        • 1.2.8 Renin Inhibitors
      • 1.3 Hypertension Drug Segment by Application
        • 1.3.1 Hypertension Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Private clinic
        • 1.3.4 Others
      • 1.4 Global Hypertension Drug Market by Region
        • 1.4.1 Global Hypertension Drug Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Hypertension Drug Market Size
        • 1.5.1 Global Hypertension Drug Revenue (2014-2025)
        • 1.5.2 Global Hypertension Drug Production (2014-2025)

      2 Global Hypertension Drug Market Competition by Manufacturers

      • 2.1 Global Hypertension Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Hypertension Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Hypertension Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Hypertension Drug Production Sites, Area Served, Product Types
      • 2.5 Hypertension Drug Market Competitive Situation and Trends
        • 2.5.1 Hypertension Drug Market Concentration Rate
        • 2.5.2 Hypertension Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Hypertension Drug Production Market Share by Regions

      • 3.1 Global Hypertension Drug Production Market Share by Regions
      • 3.2 Global Hypertension Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Hypertension Drug Production
        • 3.4.1 North America Hypertension Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Hypertension Drug Production
        • 3.5.1 Europe Hypertension Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Hypertension Drug Production (2014-2019)
        • 3.6.1 China Hypertension Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Hypertension Drug Production (2014-2019)
        • 3.7.1 Japan Hypertension Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Hypertension Drug Consumption by Regions

      • 4.1 Global Hypertension Drug Consumption by Regions
      • 4.2 North America Hypertension Drug Consumption (2014-2019)
      • 4.3 Europe Hypertension Drug Consumption (2014-2019)
      • 4.4 China Hypertension Drug Consumption (2014-2019)
      • 4.5 Japan Hypertension Drug Consumption (2014-2019)

      5 Global Hypertension Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Hypertension Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Hypertension Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Hypertension Drug Price by Type (2014-2019)
      • 5.4 Global Hypertension Drug Production Growth by Type (2014-2019)

      6 Global Hypertension Drug Market Analysis by Applications

      • 6.1 Global Hypertension Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Hypertension Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Hypertension Drug Business

      • 7.1 Lupin Limited
        • 7.1.1 Lupin Limited Hypertension Drug Production Sites and Area Served
        • 7.1.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.1.3 Lupin Limited Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis AG
        • 7.2.1 Novartis AG Hypertension Drug Production Sites and Area Served
        • 7.2.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.2.3 Novartis AG Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Daiichi - Sankyo
        • 7.3.1 Daiichi - Sankyo Hypertension Drug Production Sites and Area Served
        • 7.3.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.3.3 Daiichi - Sankyo Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Pfizer Inc
        • 7.4.1 Pfizer Inc Hypertension Drug Production Sites and Area Served
        • 7.4.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.4.3 Pfizer Inc Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Ranbaxy Laboratories Limited
        • 7.5.1 Ranbaxy Laboratories Limited Hypertension Drug Production Sites and Area Served
        • 7.5.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.5.3 Ranbaxy Laboratories Limited Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sanofi S.A
        • 7.6.1 Sanofi S.A Hypertension Drug Production Sites and Area Served
        • 7.6.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.6.3 Sanofi S.A Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 AstraZeneca Plc
        • 7.7.1 AstraZeneca Plc Hypertension Drug Production Sites and Area Served
        • 7.7.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.7.3 AstraZeneca Plc Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Johnson & Johnson Ltd
        • 7.8.1 Johnson & Johnson Ltd Hypertension Drug Production Sites and Area Served
        • 7.8.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.8.3 Johnson & Johnson Ltd Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Boehringer Ingelheim
        • 7.9.1 Boehringer Ingelheim Hypertension Drug Production Sites and Area Served
        • 7.9.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.9.3 Boehringer Ingelheim Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Merck & Co.
        • 7.10.1 Merck & Co. Hypertension Drug Production Sites and Area Served
        • 7.10.2 Hypertension Drug Product Introduction, Application and Specification
        • 7.10.3 Merck & Co. Hypertension Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Hypertension Drug Manufacturing Cost Analysis

      • 8.1 Hypertension Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Hypertension Drug
      • 8.4 Hypertension Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Hypertension Drug Distributors List
      • 9.3 Hypertension Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Hypertension Drug Market Forecast

      • 11.1 Global Hypertension Drug Production, Revenue Forecast
        • 11.1.1 Global Hypertension Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Hypertension Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Hypertension Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Hypertension Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Hypertension Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Hypertension Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Hypertension Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Hypertension Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Hypertension Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Hypertension Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Hypertension Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Hypertension Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Hypertension Drug Consumption Forecast (2019-2025)
      • 11.4 Global Hypertension Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Hypertension Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.
        Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.

        The global Hypertension Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Hypertension Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypertension Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Lupin Limited
        Novartis AG
        Daiichi - Sankyo
        Pfizer Inc
        Ranbaxy Laboratories Limited
        Sanofi S.A
        AstraZeneca Plc
        Johnson & Johnson Ltd
        Boehringer Ingelheim
        Merck & Co.

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Calcium Channel Blockers
        Diuretics
        Beta Blockers Vasodilators
        Angiotensin Converting Enzyme Inhibitors
        Alpha Blockers
        Angiotensin Receptor Blockers
        Renin Inhibitors

        Segment by Application
        Hospital
        Private clinic
        Others

        Buy now